Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BKM120 in Metastatic Castration-resistant Prostate Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Andrew J. Armstrong, MD, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01385293
First received: June 28, 2011
Last updated: September 14, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)